tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Maeder, 225 are a BUY (72.35%), 79 are a HOLD (25.4%), 7 are a SELL (2.25%).
Analyst Adam Maeder, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 61.88% that have a potential upside of 33.88% achieved within 138 days.
Adam Maeder’s has documented 622 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on RXST, Rxsight at 26-Feb-2026.
Analyst best performing recommendations are on RBOT (VICARIOUS SURGICAL).
The best stock recommendation documented was for RBOT (VICARIOUS SURGICAL) at 11/13/2024. The price target of $10.5 was fulfilled within 1 day with a profit of $1.35 (14.75%) receiving and performance score of 147.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jan-2023
$10
$13
3 years 1 months 15 days ago
(23-Jan-2023)
1/2 (50%)
$0.16 (1.63%)
70
Hold Since 04-Jan-2023
$10
$10
3 years 2 months 6 days ago
(04-Jan-2023)
5/6 (83.33%)
$0.12 (1.21%)
167
Hold Since 30-Nov-2022
$10
$14
3 years 3 months 8 days ago
(30-Nov-2022)
1/5 (20%)
$-0.13 (-1.28%)
13
Buy Since 08-Sep-2021
$9
$-1 (-10.00%)
$13
3 years 10 months 6 days ago
(04-May-2022)
1/3 (33.33%)
$3.44 (61.87%)
209
Buy Since 18-Nov-2019
$12
$2 (20.00%)
$14
4 years 15 days ago
(23-Feb-2022)
9/13 (69.23%)
$6.64 (123.88%)
124
Which stock is Adam Maeder is most bullish on?
Which stock is Adam Maeder is most reserved on?
What Year was the first public recommendation made by Adam Maeder?
